Showing results (561-570 of 748) with videos related to
Sort By:
Pageof 75
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.Journal of Personalized Medicine|December 23, 2022
The Penn Medicine BioBank: Towards a Genomics-Enabled Learning Healthcare System to Accelerate Precision Medicine in a Diverse PopulationAnurag Verma, Scott M Damrauer, Nawar Naseer, et al.Journal of Lipid Research|March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and EJohn S Millar, Michael E Lassman, Tiffany Thomas, et al.Nature Medicine|April 15, 2026
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypesChenyu Li, Shola M Richards, Ghazal Quinn, et al.Circulation. Cardiovascular Genetics|February 10, 2011
Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterolAndrew C Edmondson, Peter S Braund, Ioannis M Stylianou, et al.Circulation Research|April 24, 2015
Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian diseaseHanrui Zhang, Chenyi Xue, Rhia Shah, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 22, 2015
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyRachana Shah, Gregory J Matthews, Rhia Y Shah, et al.Clinical Pharmacology and Therapeutics|June 3, 2025
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.The Journal of Clinical Investigation|May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.Nature Genetics|June 18, 2021
A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohortsYogasudha Veturi, Anastasia Lucas, Yuki Bradford, et al.Pageof 75